Ep Wealth Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Ep Wealth Advisors, LLC
- $14.6 Billion
- Q2 2025
A detailed history of Ep Wealth Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 2,242 shares of REGN stock, worth $1.31 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,242
Previous 1,033
117.04%
Holding current value
$1.31 Million
Previous $655,000
79.69%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,441Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.52 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.31 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.24 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...